Skip to main content
OpenTrials
Completed

NCT Number: NCT04339881

NOsocomial Dissemination Risk of SARS-Cov2

To date, in France, in the context of the SARS Cov2 pandemic,both the number of affected subjects and the number of severe forms requiring hospital care are increasing.

Several nosocomial transmission clusters have already been identified in hospitals (both pediatric and adult) but there is still limited data on the nosocomial spread of SARS-Cov2.

This nosocomial transmission affects both patients and caregivers. It is important to understand the spread of the virus within the hospital. This will help to optimize procedures to prevent transmission to caregivers and hospitalizedpatients not infected with SARS Cov2, and more generally this will contribute to control the spread of SARS Cov2 in the community

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Sars-CoV2

Sex eligibility

All sexes

Study type

Observational

Primary location

Didier Guillemot

Garches, France

About this study

It is an observational study without any risk. Every participating service will be investigated for 2 consecutive days .

  • At each staff rotation, an individualsensorwill be provided toall thestaff(caregivers, administrative, students etc…) to be worn duringtheirworking hours. Also a sensor will be placed at each patient's bedside.
  • In addition, epidemiological data relating to socio-demographic characteristics, profession, protective measures will be collectedfrom hospitalstaff. Also, some data from the 'entrepot des données de santé" regarding individual carepathways in the hospitalwill be extracted.
  • A map of the unit, specifying the location of each patient will be made.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

for patients:

  • Informed of the purpose of the study and having expressed his non-opposition or of a relative (if the patient's state of health does not allow it)
  • Hospitalized in one of the participating departments

Inclusion criteria

for hospital staff:

  • Informed of the objective of the study and having expressed his no opposition
  • Having daily contact with patients hospitalized in participating departments

Inclusion criteria

for patient visitors

  • Informed of the purpose of the study and having expressed his non-opposition
  • Having daily contacts with patients hospitalized in the participating departments

Exclusion criteria

for evryone (patient, hospital staff and patients visitors) :

  • Refuse to participate

Treatment and study plan

Primary outcomes

  1. Understanding the dissemination of SARS Cov2 in hospital

    Time frame: 2 days

    In each unit, during 2 days, Patients and all staff (caregivers, administrative, students…) will carry an individualsensorwhich will regularly measure the proximity between 2 sensors

Secondary outcomes

  1. Optimizing hospital strategies to prevent transmission to caregivers and not infected hospitalized patients with SARSCov2

    Time frame: 8 weeks

Sponsors and collaborators

Lead sponsor

Assistance Publique - Hôpitaux de Paris

Other

Registry information

Acronym: NODS-Cov2

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Apr 9, 2020
Registry last updated
Nov 23, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.